Mitogen Induced Blood Lymphocyte DNA Synthesis as a Prognostic Indicator in Patients with Non-Hodgkin's Lymphomas in Clinical Remission
Open Access
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Acta Radiologica: Oncology
- Vol. 22 (6) , 455-459
- https://doi.org/10.3109/02841868309135970
Abstract
(1983). Mitogen Induced Blood Lymphocyte DNA Synthesis as a Prognostic Indicator in Patients with Non-Hodgkin's Lymphomas in Clinical Remission. Acta Radiologica: Oncology: Vol. 22, No. 6, pp. 455-459.Keywords
This publication has 14 references indexed in Scilit:
- Longitudinal studies of blood lymphocyte functions in non-Hodgkin's lymphomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Immunocompetence and malignant lymphoma: Immunologic status before therapyCancer, 1981
- Immune dysfunction in non-Hodgkin's lymphomaCancer, 1980
- Chemotherapy of advanced non-Hodgkin's lymphomaClinics in Haematology, 1979
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyThe American Journal of Medicine, 1977
- Immunologic Abnormalities in Patients With Malignant Lymphoproliferative Diseases2JNCI Journal of the National Cancer Institute, 1977
- Cellular and Humoral Immunity in Non-Hodgkin’s Lymphoma: Correlation of Immunodeficiencies with Clinicopathologic FactorsAmerican Journal of Clinical Pathology, 1977
- Immunodeficiency in patients with non-Hodgkin lymphomasBlood, 1977
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972